Portfolio

ATPlus Twitter



Newsletter


As you are undoubtedly aware, the cost of autism—both human and financial—is enormous. The rate of ASD has continued to rise for more than two decades, now affecting one child in 50 in the USA and 1 in 64 in the UK. The increased rates can no longer be attributed to better recognition, and current scientific evidence demonstrates that ASD is medical in nature and treatable.

Tragically, as headlines and the lived experience of thousands of families will attest, the medical needs of this population are often overlooked, misunderstood, or actively ignored. A paradigm shift is currently taking place in the scientific and medical community, offering greater potentials for intervention. This message needs to be shared with families of children with ASD, teachers, health workers, government officials and all tax payers in the UK: the new paradigm of autism as a treatable condition offers tens of thousands of people a better chance for an improved quality of life.

Click here for a copy of the scientific review written by Treating Autism and Autism Treatment Trust, Medical Comorbidities in Autism Spectrum Disorders 2013 .